Novo nabs Cardior in €1B deal, gaining phase II-stage miRNA drug | BioWorld
… disease-modifying heart failure candidate in the hands of a big pharma player in the midst of establishing its presence in cardiovascular disease.
BREAKING NEWS
1 Tablespoon Daily: What It Does (Dosing high-polyphenol extra virgin olive oil) |
Polyphenols Explained Simply |
Why “Smooth” Olive Oil Is Usually Weaker |
Grocery Store vs Real EVOO |
LIQUID MEDICINE: EVOO THAT ACTUALLY WORKS |
08/25/2026
